The best approach is balanced: keep the metabolic benefits, understand the retinal risk, and monitor the eye appropriately
Based on recent studies, SGLT2 inhibitors (SGLTis) are generally considered superior to GLP-1 receptor agonists (GLP-1s) for slowing the progression of chronic kidney disease
Individual results vary and depend on dose, duration and lifestyle changes alongside treatment
Diabetes Obes Metab 24:94105 Funding This work was supported by the funding from The Foundation of Hope for Research and Treatment of Mental Illness and in part by the Bowles Center for Alcohol Studies
For the first round of testing, I mixed a single serving of each powder with 12 ounces of water (or the amount recommended on the label) in a blender bottle, shaking for at least 30 seconds
This leads to fewer breathing interruptions and better overall sleep quality